The start-up Modern Fertility sees "a world where getting fertility tested is as routine as getting a pap smear," says founder Afton Vechery. It’s one of a clutch of tech companies looking to crack the fertility tech market in Silicon Valley.
Backed by $7 million in venture capital, Modern Fertility just launched a $199 at-home testing kit much like those sold by ancestry websites. It tests for 9 hormones related to ovarian reserve and reproductive health. It can’t tell you when to try to conceive or what your chances are, but it promises bespoke insights into when a woman will likely hit menopause, and options for egg freezing and IVF. At $70,000 in pre-orders, the information, however limited, is selling.